We are live on ! Find out more
MAG

Millrace Asset Group Portfolio holdings

AUM $98.4M
1-Year Est. Return 63.71%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+63.71%
3 Year Est. Return
+112.82%
5 Year Est. Return
+625.06%
10 Year Est. Return
+4,658.38%
AUM
$88.1M
AUM Growth
+$8.94M
Cap. Flow
+$2.94M
Cap. Flow %
3.34%
Top 10 Hldgs %
40.39%
Holding
66
New
14
Increased
20
Reduced
14
Closed
18

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$2.54M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$2.54M
3
EXTR icon
Extreme Networks
EXTR
+$2.02M
4
DCGO icon
DocGo
DCGO
+$2.01M
5
AZTA icon
Azenta
AZTA
+$1.96M

Top Sells

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$1.65M
2
INVE icon
Identive
INVE
+$1.56M
3
ATRC icon
AtriCure
ATRC
+$1.45M
4
LFG
Archaea Energy Inc.
LFG
+$1.4M
5
BW icon
Babcock & Wilcox
BW
+$1.39M

Sector Composition

Rank Sector Weight
1 Technology 42.27%
2 Healthcare 22.85%
3 Consumer Discretionary 11.4%
4 Industrials 11.09%
5 Consumer Staples 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPSN
26
DELISTED
LivePerson
LPSN
$1.55M 1.76%
10,193
+2,647
+35% +$424K
PETQ
27
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1.53M 1.74%
+166,508
New +$1.55M
DXLG icon
28
Destination XL Group
DXLG
$35.5M
$1.52M 1.73%
+225,799
New +$1.45M
AXTI icon
29
AXT Inc
AXTI
$3.74B
$1.45M 1.65%
331,762
+292,560
+746% +$1.43M
CALX icon
30
Calix
CALX
$2.22B
$1.37M 1.55%
19,991
-11,341
-36% -$762K
SYNA icon
31
Synaptics
SYNA
$3.95B
$1.37M 1.55%
14,353
+250
+2% +$24K
MMSI icon
32
Merit Medical Systems
MMSI
$5.2B
$1.3M 1.48%
18,478
+10,650
+136% +$711K
AUGX
33
DELISTED
Augmedix, Inc. Common Stock
AUGX
$1.29M 1.46%
825,218
+539
+0.1% +$687
LSPD icon
34
Lightspeed Commerce
LSPD
$1.29B
$1.28M 1.46%
+89,874
New +$1.46M
NDLS icon
35
Noodles & Co
NDLS
$82M
$1.24M 1.41%
28,255
-2,222
-7% -$97.4K
ENVX icon
36
Enovix
ENVX
$663M
$1.19M 1.35%
109,418
+72
+0.1% +$886
AMNB
37
DELISTED
American National Bankshares Inc
AMNB
$1.12M 1.28%
30,439
-6,251
-17% -$228K
TMDX icon
38
Transmedics
TMDX
$2.98B
$1.11M 1.26%
17,940
-2,378
-12% -$126K
ACLS icon
39
Axcelis
ACLS
$3.5B
$949K 1.08%
11,960
-11,928
-50% -$840K
CSBR icon
40
Champions Oncology
CSBR
$71M
$875K 0.99%
194,010
-152,966
-44% -$999K
RPAY icon
41
Repay Holdings
RPAY
$295M
$744K 0.84%
92,448
-24,680
-21% -$178K
VECO icon
42
Veeco
VECO
$2.74B
$711K 0.81%
38,271
-17,903
-32% -$336K
CERS icon
43
Cerus
CERS
$514M
$708K 0.8%
193,986
-8,718
-4% -$32.9K
SMTC icon
44
Semtech
SMTC
$13.7B
$686K 0.78%
+23,919
New +$678K
MRCY icon
45
Mercury Systems
MRCY
$4.87B
$669K 0.76%
+14,950
New +$707K
SSYS icon
46
Stratasys
SSYS
$661M
$569K 0.65%
+48,000
New +$640K
SITM icon
47
SiTime
SITM
$16.8B
$328K 0.37%
3,229
+2
+0.1% +$189
PRO
48
DELISTED
PROS Holdings
PRO
$52K 0.06%
+2,153
New +$52.8K
ACIW icon
49
ACI Worldwide
ACIW
$5.26B
– –
-39,653
Closed -$829K
ATRC icon
50
AtriCure
ATRC
$2.84B
– –
-37,051
Closed -$1.45M
1
2
3

Similar funds

SAM
Soditic Asset Management Tonbridge, United Kingdom $98.4M AUM 36.65% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
AIM
Aquila Investment Management New York $89.9M AUM 29.86% 1-Year Est. Return
IG
Inherent Group New York $108M AUM 55.34% 1-Year Est. Return
G1
Greylock 15 Menlo Park, California $85.6M AUM 199.44% 1-Year Est. Return
BGI
BlueDrive Global Investors London, United Kingdom $85.4M AUM 19.84% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SC
Sinecera Capital Austin, Texas $82.9M AUM 21.76% 1-Year Est. Return

Millrace Asset Group's Q4 2022 Portfolio in Review

As of Q4 2022, Millrace Asset Group held 66 positions worth $88.1M, up 11% from $79.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Millrace Asset Group deployed $2.94M of net new capital in Q4 2022, opening 14 new positions and adding to 20 existing holdings. Its largest new stake was Tandem Diabetes Care: 56,211 shares worth $2.53M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Champions Oncology, an estimated $999K trimmed.

  • Millrace Asset Group's largest Q4 2022 buy was Tandem Diabetes Care: 56,211 shares worth $2.53M.
  • Millrace Asset Group added most to AXT Inc in Q4 2022, an estimated $1.43M increase.
  • Millrace Asset Group's biggest Q4 2022 reduction was Champions Oncology, cutting an estimated $999K.
  • Millrace Asset Group fully exited Castle Biosciences in Q4 2022, selling an estimated $1.65M.
  • Millrace Asset Group's ten largest holdings make up 40% of its $88.1M portfolio in Q4 2022.
  • Millrace Asset Group opened 14 new positions and closed 18 in Q4 2022.
  • Millrace Asset Group's portfolio value rose 11% quarter-over-quarter to $88.1M.

Based on Millrace Asset Group's 13F filing for Q4 2022, filed 13 Feb 2023.